APVO
Aptevo Therapeutics Inc.
+0.07 (+4.07%)1.79USD381K成交股數3.2M市值0.0本益比(近四季)1.0股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.7M | 3.9M | 3.5M | 4.0M | 3.3M | 3.6M | 3.1M | 3.6M | 3.8M | 3.6M | 3.9M | 5.5M |
| 銷售管理費用 | 2.7M | 2.9M | 2.5M | 3.6M | 2.9M | 2.8M | 2.1M | 2.4M | 3.2M | 2.8M | 2.7M | 2.7M |
| 營業利益 | −6.4M+3% | −6.8M+6% | −6.0M+15% | −7.6M+26% | −6.2M-11% | −6.5M+2% | −5.2M-21% | −6.0M-26% | −7.0M | −6.4M | −6.6M | −8.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −6.4M+2% | −6.7M+5% | −5.8M+14% | −7.5M+28% | −6.2M-9% | −6.4M+9% | −5.1M-19% | −5.9M-26% | −6.8M | −5.9M | −6.3M | −7.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -5.31-96% | -6.41-100% | 1648.06-561% | -2.23-100% | -151.29-59% | -1581.81-30% | -357.86+1515% | -1236.96+2193% | -368.21 | -2258.10 | -22.16 | -53.95 |
| 稀釋股數 | 1.2M | 1.1M | 316K | 4.0M | 41.0K | 4.1K | 14.3K | 4.8K | 18.6K | 7.5K | 286K | 147K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 9.8M | 14.5M | 21.6M | 21.1M | 9.4M | 2.1M | 7.8M | 8.1M | 10.3M | 16.9M | 19.1M | 21.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 14.5M | 19.9M | 27.2M | 27.0M | 15.6M | 8.3M | 15.1M | 14.9M | 17.6M | 24.8M | 27.1M | 28.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | 0 | 0 | 0 |
| 總負債 | 8.5M | 8.3M | 9.8M | 9.6M | 9.1M | 9.8M | 10.7M | 10.5M | 11.5M | 12.6M | 12.4M | 12.7M |
| 股東權益 | 6.0M | 11.6M | 17.4M | 17.4M | 6.5M | −1.5M | 4.4M | 4.5M | 6.1M | 12.2M | 14.7M | 16.3M |
| 負債比 | 58.4% | 41.7% | 36.1% | 35.6% | 58.2% | 117.7% | 70.8% | 70.1% | 65.4% | 50.8% | 45.7% | 43.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | 16.9M | 19.1M | 21.0M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.0M+21% | – | – | – | −6.6M | – | – | −6.7M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 35K | – | – | – | 61K | – | – | 106K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2019 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2019 年度 · 32.4M
| 產品 | 32.4M | 100.0% | +40.3% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −26.0M | –% | -87.27 | – |
| FY2024 | – | – | −24.1M | –% | -31460.23 | – |
| FY2023 | – | – | −17.4M | –% | -2316.83 | – |
| FY2022 | 3.1M | -74.7% | 8.0M | 257.8% | 1.57 | −21.1M |
| FY2021 | 12.3M | +185.3% | −28.5M | -231.5% | -6.07 | −22.4M |
| FY2020 | 4.3M | -86.7% | −17.8M | -411.9% | -5.23 | −29.4M |
| FY2019 | 32.4M | +40.6% | −40.4M | -124.7% | -13.86 | −42.5M |
| FY2018 | 23.1M | – | −53.7M | -232.8% | -2.39 | −52.4M |